Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) — 20-F Filings
All 20-F filings from Cordyceps Sunshine Biotech Holdings Co., Ltd.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
Cordyceps Sunshine Biotech Soars: Revenue Up 45%, Net Income Jumps 81%
— Jun 13, 2025 Risk: medium
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported a significant increase in revenue to $15.2 million for the fiscal year ended December 31, 2024, up from $ -
Cordyceps Sunshine Biotech Files 2023 Annual Report
— Jul 5, 2024 Risk: medium
Cordyceps Sunshine Biotech Holdings Co., Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2023. The company, incorporated in the
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX